Regeneron (REGN) Tops Q1 EPS by 50c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $612.50 +0.42%
EPS Growth %: -15.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -15.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $9.47, $0.50 better than the analyst estimate of $8.97. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.48 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- Shopify To Bar Vapes As U.s. Authorities Crack Down On Illegal Industry - Reuters
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
